John Welsh
Concepts (300)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| High-Throughput Screening Assays | 8 | 2025 | 176 | 1.970 |
Why?
| | Biological Products | 4 | 2025 | 256 | 1.600 |
Why?
| | Autistic Disorder | 4 | 2022 | 211 | 1.540 |
Why?
| | Antibodies, Monoclonal | 8 | 2025 | 1505 | 1.520 |
Why?
| | Gap Junctions | 4 | 2016 | 67 | 1.240 |
Why?
| | Olivary Nucleus | 4 | 2016 | 19 | 1.100 |
Why?
| | Autism Spectrum Disorder | 3 | 2022 | 410 | 0.990 |
Why?
| | Cricetulus | 3 | 2024 | 114 | 0.900 |
Why?
| | Action Potentials | 5 | 2014 | 502 | 0.880 |
Why?
| | Membrane Potentials | 2 | 2016 | 278 | 0.840 |
Why?
| | Filtration | 1 | 2024 | 70 | 0.810 |
Why?
| | Bioreactors | 1 | 2024 | 51 | 0.810 |
Why?
| | Neurons | 10 | 2021 | 1639 | 0.800 |
Why?
| | Chromatography | 5 | 2024 | 27 | 0.790 |
Why?
| | Cerebellum | 5 | 2022 | 224 | 0.770 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 2 | 2014 | 229 | 0.720 |
Why?
| | Biological Clocks | 2 | 2016 | 48 | 0.710 |
Why?
| | Intellectual Disability | 1 | 2022 | 174 | 0.660 |
Why?
| | Connexins | 3 | 2006 | 54 | 0.600 |
Why?
| | Chromatography, Ion Exchange | 4 | 2025 | 57 | 0.570 |
Why?
| | Publishing | 1 | 2018 | 115 | 0.500 |
Why?
| | Cell-Free System | 3 | 2013 | 53 | 0.480 |
Why?
| | Hemagglutinin Glycoproteins, Influenza Virus | 2 | 2013 | 29 | 0.470 |
Why?
| | Neuronal Plasticity | 3 | 2021 | 306 | 0.450 |
Why?
| | Auditory Cortex | 2 | 2015 | 46 | 0.430 |
Why?
| | Purkinje Cells | 3 | 2005 | 65 | 0.430 |
Why?
| | Influenza Vaccines | 3 | 2017 | 530 | 0.420 |
Why?
| | Influenza A Virus, H1N1 Subtype | 2 | 2013 | 156 | 0.420 |
Why?
| | Computer Simulation | 3 | 2024 | 1021 | 0.420 |
Why?
| | Medulla Oblongata | 1 | 2014 | 37 | 0.420 |
Why?
| | Electrical Synapses | 1 | 2014 | 6 | 0.420 |
Why?
| | Escherichia coli | 5 | 2013 | 854 | 0.410 |
Why?
| | Recombinant Proteins | 2 | 2014 | 1363 | 0.400 |
Why?
| | Brain | 4 | 2021 | 2934 | 0.390 |
Why?
| | Heat-Shock Proteins | 2 | 2011 | 134 | 0.390 |
Why?
| | Research Design | 2 | 2020 | 1129 | 0.380 |
Why?
| | Antigens, Viral | 2 | 2013 | 182 | 0.370 |
Why?
| | CHO Cells | 3 | 2024 | 165 | 0.370 |
Why?
| | Macaca fascicularis | 2 | 2013 | 70 | 0.360 |
Why?
| | Periodicity | 3 | 2014 | 58 | 0.360 |
Why?
| | Escherichia coli Proteins | 2 | 2011 | 207 | 0.360 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2018 | 1742 | 0.350 |
Why?
| | Peptidylprolyl Isomerase | 1 | 2011 | 9 | 0.340 |
Why?
| | Rats | 9 | 2014 | 5570 | 0.320 |
Why?
| | Luciferases | 2 | 2010 | 152 | 0.320 |
Why?
| | Animals | 22 | 2024 | 37948 | 0.310 |
Why?
| | Ethanol | 2 | 2013 | 627 | 0.310 |
Why?
| | Copepoda | 1 | 2009 | 4 | 0.310 |
Why?
| | Luminescence | 1 | 2009 | 38 | 0.300 |
Why?
| | Auditory Perception | 1 | 2010 | 114 | 0.300 |
Why?
| | Mutant Proteins | 1 | 2009 | 104 | 0.300 |
Why?
| | Ribosomes | 1 | 2011 | 196 | 0.300 |
Why?
| | Motor Activity | 2 | 2005 | 723 | 0.300 |
Why?
| | Biotechnology | 2 | 2020 | 46 | 0.290 |
Why?
| | Wakefulness | 1 | 2010 | 170 | 0.290 |
Why?
| | Drug Discovery | 2 | 2020 | 153 | 0.290 |
Why?
| | Protein Biosynthesis | 2 | 2011 | 455 | 0.280 |
Why?
| | N-Methylaspartate | 2 | 2021 | 43 | 0.280 |
Why?
| | Workflow | 3 | 2024 | 182 | 0.280 |
Why?
| | Pseudolymphoma | 1 | 2008 | 1 | 0.270 |
Why?
| | Drug Eruptions | 1 | 2008 | 28 | 0.270 |
Why?
| | Calcium | 1 | 2014 | 1182 | 0.270 |
Why?
| | Methylphenidate | 1 | 2008 | 49 | 0.260 |
Why?
| | Sarcoma, Kaposi | 1 | 2008 | 83 | 0.260 |
Why?
| | Behcet Syndrome | 1 | 2007 | 19 | 0.260 |
Why?
| | Urticaria | 2 | 2007 | 38 | 0.250 |
Why?
| | Paroxetine | 1 | 2006 | 10 | 0.250 |
Why?
| | Lichen Planus | 1 | 2006 | 3 | 0.240 |
Why?
| | Vasculitis | 1 | 2006 | 69 | 0.240 |
Why?
| | Blinking | 2 | 2021 | 11 | 0.240 |
Why?
| | Models, Theoretical | 2 | 2020 | 578 | 0.240 |
Why?
| | Diethylamines | 1 | 2005 | 5 | 0.230 |
Why?
| | Central Nervous System Stimulants | 1 | 2008 | 185 | 0.230 |
Why?
| | Skin | 2 | 2008 | 762 | 0.230 |
Why?
| | Vaccines, Virus-Like Particle | 2 | 2017 | 5 | 0.230 |
Why?
| | Cortical Synchronization | 1 | 2005 | 12 | 0.220 |
Why?
| | Myoclonus | 2 | 2002 | 17 | 0.220 |
Why?
| | Quantitative Structure-Activity Relationship | 1 | 2025 | 20 | 0.220 |
Why?
| | Thiophenes | 1 | 2005 | 121 | 0.220 |
Why?
| | Neural Inhibition | 1 | 2005 | 178 | 0.210 |
Why?
| | Alcoholism | 1 | 2011 | 813 | 0.210 |
Why?
| | Learning | 2 | 2005 | 448 | 0.200 |
Why?
| | Rats, Sprague-Dawley | 4 | 2014 | 2521 | 0.200 |
Why?
| | Tremor | 1 | 2004 | 98 | 0.200 |
Why?
| | Anion Exchange Resins | 1 | 2023 | 8 | 0.190 |
Why?
| | Patch-Clamp Techniques | 2 | 2016 | 289 | 0.190 |
Why?
| | Muscles | 1 | 2004 | 332 | 0.190 |
Why?
| | Nerve Net | 1 | 2006 | 284 | 0.190 |
Why?
| | Chromatography, Affinity | 1 | 2022 | 80 | 0.190 |
Why?
| | Prosencephalon | 1 | 2022 | 53 | 0.190 |
Why?
| | Nervous System Malformations | 1 | 2022 | 46 | 0.180 |
Why?
| | Amino Acid Transport System X-AG | 1 | 2002 | 5 | 0.180 |
Why?
| | Journal Impact Factor | 2 | 2020 | 29 | 0.180 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2022 | 187 | 0.180 |
Why?
| | Methoxyhydroxyphenylglycol | 1 | 2021 | 13 | 0.180 |
Why?
| | Recombinant Fusion Proteins | 3 | 2011 | 667 | 0.170 |
Why?
| | Protein Interaction Maps | 1 | 2021 | 53 | 0.170 |
Why?
| | Symporters | 1 | 2002 | 48 | 0.170 |
Why?
| | Protein Structure, Tertiary | 5 | 2019 | 849 | 0.170 |
Why?
| | Point Mutation | 1 | 2002 | 242 | 0.160 |
Why?
| | Amino Acid Substitution | 1 | 2002 | 303 | 0.160 |
Why?
| | Synapses | 2 | 2021 | 437 | 0.160 |
Why?
| | Skin Neoplasms | 1 | 2008 | 850 | 0.160 |
Why?
| | Equivalence Trials as Topic | 1 | 2020 | 36 | 0.160 |
Why?
| | Proteins | 2 | 2025 | 1016 | 0.160 |
Why?
| | Diagnosis, Differential | 4 | 2008 | 1501 | 0.160 |
Why?
| | Mutation, Missense | 1 | 2002 | 338 | 0.150 |
Why?
| | Cell Communication | 1 | 2002 | 325 | 0.150 |
Why?
| | Models, Biological | 2 | 2024 | 1811 | 0.150 |
Why?
| | Models, Neurological | 1 | 2002 | 250 | 0.150 |
Why?
| | PC12 Cells | 2 | 2014 | 42 | 0.150 |
Why?
| | Developmental Disabilities | 1 | 2022 | 279 | 0.150 |
Why?
| | Serotonin | 1 | 2002 | 294 | 0.150 |
Why?
| | Cerebral Cortex | 1 | 2003 | 470 | 0.150 |
Why?
| | Circular Dichroism | 1 | 2019 | 144 | 0.150 |
Why?
| | Automation | 1 | 2019 | 104 | 0.150 |
Why?
| | Algorithms | 2 | 2018 | 1844 | 0.150 |
Why?
| | Spectrometry, Fluorescence | 1 | 2019 | 159 | 0.150 |
Why?
| | Polymers | 1 | 2023 | 492 | 0.140 |
Why?
| | Angina Pectoris | 1 | 2018 | 75 | 0.140 |
Why?
| | Brain Ischemia | 1 | 2002 | 358 | 0.140 |
Why?
| | Humans | 24 | 2022 | 144671 | 0.130 |
Why?
| | Hemagglutinins | 1 | 2017 | 10 | 0.130 |
Why?
| | Microelectrodes | 2 | 2010 | 48 | 0.130 |
Why?
| | N-Acetylneuraminic Acid | 2 | 2017 | 16 | 0.130 |
Why?
| | Proteome | 1 | 2021 | 515 | 0.120 |
Why?
| | Protein Conformation | 1 | 2019 | 935 | 0.120 |
Why?
| | Biotin | 1 | 2016 | 32 | 0.120 |
Why?
| | Bacteriophage T4 | 2 | 2013 | 17 | 0.120 |
Why?
| | Macaca mulatta | 1 | 2016 | 186 | 0.110 |
Why?
| | Electric Stimulation | 1 | 2016 | 277 | 0.110 |
Why?
| | Dendrites | 1 | 2016 | 104 | 0.110 |
Why?
| | Longitudinal Studies | 1 | 2022 | 2942 | 0.110 |
Why?
| | Language Development Disorders | 1 | 2015 | 40 | 0.110 |
Why?
| | Cognition | 1 | 2003 | 1263 | 0.110 |
Why?
| | Child Development Disorders, Pervasive | 1 | 2015 | 62 | 0.110 |
Why?
| | In Vitro Techniques | 1 | 2016 | 1046 | 0.110 |
Why?
| | Brain Waves | 1 | 2015 | 45 | 0.110 |
Why?
| | Nerve Tissue Proteins | 2 | 2012 | 590 | 0.100 |
Why?
| | alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2014 | 15 | 0.100 |
Why?
| | gamma-Aminobutyric Acid | 2 | 2013 | 194 | 0.100 |
Why?
| | Hydrogen-Ion Concentration | 3 | 2024 | 562 | 0.100 |
Why?
| | Specimen Handling | 1 | 2015 | 187 | 0.100 |
Why?
| | Ion Transport | 1 | 2014 | 62 | 0.100 |
Why?
| | Evoked Potentials, Auditory | 1 | 2015 | 180 | 0.100 |
Why?
| | Influenza, Human | 2 | 2017 | 618 | 0.100 |
Why?
| | Mutation | 3 | 2012 | 4081 | 0.100 |
Why?
| | Animals, Newborn | 1 | 2016 | 890 | 0.100 |
Why?
| | Neural Conduction | 1 | 2013 | 92 | 0.100 |
Why?
| | Hepatitis B Core Antigens | 1 | 2013 | 2 | 0.100 |
Why?
| | Acoustic Stimulation | 2 | 2015 | 332 | 0.100 |
Why?
| | Toll-Like Receptor 5 | 1 | 2013 | 18 | 0.100 |
Why?
| | Dendritic Spines | 1 | 2014 | 69 | 0.100 |
Why?
| | Flagellin | 1 | 2013 | 19 | 0.100 |
Why?
| | Percutaneous Coronary Intervention | 1 | 2018 | 547 | 0.090 |
Why?
| | Fetuins | 1 | 2012 | 3 | 0.090 |
Why?
| | Prospective Studies | 2 | 2022 | 7994 | 0.090 |
Why?
| | Conditioning, Eyelid | 2 | 2021 | 2 | 0.090 |
Why?
| | Receptors, GABA-A | 1 | 2013 | 137 | 0.090 |
Why?
| | Alopecia | 1 | 2012 | 37 | 0.090 |
Why?
| | Calcium Channels, T-Type | 1 | 2014 | 104 | 0.090 |
Why?
| | Cerebellar Diseases | 1 | 2012 | 27 | 0.090 |
Why?
| | RNA Interference | 1 | 2014 | 473 | 0.090 |
Why?
| | Cell Adhesion Molecules, Neuronal | 1 | 2012 | 42 | 0.090 |
Why?
| | Neurotransmitter Agents | 1 | 2012 | 83 | 0.090 |
Why?
| | Child | 4 | 2022 | 22600 | 0.090 |
Why?
| | Coronary Artery Disease | 1 | 2018 | 743 | 0.090 |
Why?
| | Infant | 2 | 2022 | 10023 | 0.090 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2012 | 324 | 0.090 |
Why?
| | Cohort Studies | 1 | 2022 | 5957 | 0.090 |
Why?
| | Movement Disorders | 1 | 2012 | 70 | 0.090 |
Why?
| | Transfection | 2 | 2006 | 924 | 0.090 |
Why?
| | Amino Acid Sequence | 2 | 2020 | 2136 | 0.090 |
Why?
| | Serine Endopeptidases | 1 | 2012 | 129 | 0.090 |
Why?
| | Prokaryotic Initiation Factor-2 | 1 | 2011 | 1 | 0.090 |
Why?
| | Adjuvants, Immunologic | 1 | 2013 | 245 | 0.090 |
Why?
| | Extracellular Matrix Proteins | 1 | 2012 | 156 | 0.080 |
Why?
| | Gene-Environment Interaction | 1 | 2012 | 177 | 0.080 |
Why?
| | Translating | 1 | 2011 | 50 | 0.080 |
Why?
| | Glutamic Acid | 1 | 2012 | 254 | 0.080 |
Why?
| | Electrophysiology | 1 | 2010 | 218 | 0.080 |
Why?
| | Sarcoidosis | 1 | 2012 | 163 | 0.080 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 835 | 0.080 |
Why?
| | Adenosine Triphosphatases | 1 | 2011 | 161 | 0.080 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2010 | 76 | 0.080 |
Why?
| | Protein Folding | 3 | 2019 | 277 | 0.070 |
Why?
| | Biomarkers | 1 | 2020 | 4261 | 0.070 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2011 | 187 | 0.070 |
Why?
| | Male | 9 | 2021 | 72431 | 0.070 |
Why?
| | Phenotype | 2 | 2020 | 3147 | 0.070 |
Why?
| | Adenosine Triphosphate | 1 | 2011 | 501 | 0.070 |
Why?
| | Cardiovascular Diseases | 1 | 2020 | 2172 | 0.070 |
Why?
| | Cognition Disorders | 1 | 2012 | 539 | 0.070 |
Why?
| | Dermatitis Herpetiformis | 1 | 2007 | 2 | 0.070 |
Why?
| | Penile Diseases | 1 | 2007 | 5 | 0.060 |
Why?
| | Child, Preschool | 1 | 2022 | 11790 | 0.060 |
Why?
| | Oral Ulcer | 1 | 2007 | 11 | 0.060 |
Why?
| | Time Factors | 1 | 2018 | 7140 | 0.060 |
Why?
| | Electroencephalography | 1 | 2010 | 555 | 0.060 |
Why?
| | Ulcer | 1 | 2007 | 37 | 0.060 |
Why?
| | Protein Denaturation | 2 | 2019 | 71 | 0.060 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 5870 | 0.060 |
Why?
| | Joint Diseases | 1 | 2007 | 61 | 0.060 |
Why?
| | Lentivirus | 1 | 2006 | 61 | 0.060 |
Why?
| | Lymphoma | 1 | 2008 | 233 | 0.060 |
Why?
| | Mitochondria | 1 | 2012 | 984 | 0.060 |
Why?
| | Oxidative Stress | 1 | 2012 | 1338 | 0.060 |
Why?
| | Female | 7 | 2021 | 78304 | 0.060 |
Why?
| | Neurophysiology | 1 | 2005 | 13 | 0.060 |
Why?
| | Molecular Sequence Data | 1 | 2009 | 2909 | 0.060 |
Why?
| | Physical Examination | 1 | 2006 | 240 | 0.050 |
Why?
| | Dyslexia | 1 | 2005 | 54 | 0.050 |
Why?
| | Endoplasmic Reticulum | 2 | 2010 | 264 | 0.050 |
Why?
| | Protein Binding | 1 | 2011 | 2243 | 0.050 |
Why?
| | Antigens, CD | 1 | 2008 | 552 | 0.050 |
Why?
| | Sudden Infant Death | 1 | 2005 | 39 | 0.050 |
Why?
| | Hypoxia | 2 | 2002 | 1193 | 0.050 |
Why?
| | Conditioning, Classical | 1 | 2005 | 119 | 0.050 |
Why?
| | Osmolar Concentration | 1 | 2024 | 169 | 0.050 |
Why?
| | Drug Industry | 1 | 2024 | 49 | 0.050 |
Why?
| | Depressive Disorder | 1 | 2006 | 386 | 0.050 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 2008 | 423 | 0.050 |
Why?
| | Polysorbates | 1 | 2023 | 42 | 0.050 |
Why?
| | Transcription Factors | 1 | 2011 | 1726 | 0.050 |
Why?
| | Lower Extremity | 1 | 2007 | 440 | 0.050 |
Why?
| | Cricetinae | 1 | 2023 | 296 | 0.050 |
Why?
| | Nerve Fibers | 1 | 2002 | 105 | 0.050 |
Why?
| | Amnesia, Retrograde | 1 | 2002 | 6 | 0.040 |
Why?
| | Glutamate Plasma Membrane Transport Proteins | 1 | 2002 | 7 | 0.040 |
Why?
| | Excitatory Amino Acid Transporter 4 | 1 | 2002 | 2 | 0.040 |
Why?
| | Fructose-Bisphosphate Aldolase | 1 | 2002 | 10 | 0.040 |
Why?
| | Subcellular Fractions | 1 | 2002 | 73 | 0.040 |
Why?
| | Genes, Dominant | 1 | 2002 | 100 | 0.040 |
Why?
| | Receptors, Glutamate | 1 | 2002 | 26 | 0.040 |
Why?
| | Excitatory Amino Acid Agonists | 1 | 2021 | 42 | 0.040 |
Why?
| | Disease Models, Animal | 1 | 2012 | 4539 | 0.040 |
Why?
| | COS Cells | 1 | 2002 | 177 | 0.040 |
Why?
| | Golgi Apparatus | 1 | 2002 | 99 | 0.040 |
Why?
| | DNA, Complementary | 1 | 2002 | 273 | 0.040 |
Why?
| | Antibodies, Viral | 2 | 2017 | 672 | 0.040 |
Why?
| | Brain Stem | 1 | 2002 | 97 | 0.040 |
Why?
| | Epilepsies, Myoclonic | 1 | 2002 | 59 | 0.040 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2002 | 374 | 0.040 |
Why?
| | Thermodynamics | 1 | 2023 | 425 | 0.040 |
Why?
| | Signal Transduction | 1 | 2014 | 5185 | 0.040 |
Why?
| | Microscopy, Fluorescence | 1 | 2002 | 407 | 0.040 |
Why?
| | Protein Transport | 1 | 2002 | 437 | 0.040 |
Why?
| | HeLa Cells | 1 | 2002 | 632 | 0.040 |
Why?
| | Cell Death | 1 | 2002 | 382 | 0.040 |
Why?
| | Research Report | 1 | 2020 | 86 | 0.040 |
Why?
| | Endpoint Determination | 1 | 2020 | 84 | 0.040 |
Why?
| | Fluorescent Dyes | 1 | 2002 | 333 | 0.040 |
Why?
| | Neural Pathways | 1 | 2002 | 311 | 0.040 |
Why?
| | Magnetic Resonance Imaging | 1 | 2012 | 3888 | 0.040 |
Why?
| | Urea | 1 | 2019 | 84 | 0.040 |
Why?
| | Rituximab | 1 | 2020 | 211 | 0.040 |
Why?
| | Protein Structure, Secondary | 1 | 2019 | 365 | 0.040 |
Why?
| | Protein Engineering | 1 | 2020 | 122 | 0.040 |
Why?
| | Cells, Cultured | 1 | 2006 | 4110 | 0.030 |
Why?
| | China | 1 | 2018 | 269 | 0.030 |
Why?
| | Homeostasis | 1 | 2021 | 639 | 0.030 |
Why?
| | Protein Refolding | 1 | 2016 | 2 | 0.030 |
Why?
| | Drug Contamination | 1 | 2015 | 53 | 0.030 |
Why?
| | Aged, 80 and over | 1 | 2008 | 8284 | 0.030 |
Why?
| | Magnetoencephalography | 1 | 2015 | 161 | 0.030 |
Why?
| | GABA-A Receptor Antagonists | 1 | 2013 | 19 | 0.030 |
Why?
| | Adult | 2 | 2008 | 40489 | 0.030 |
Why?
| | Middle Aged | 3 | 2018 | 35971 | 0.030 |
Why?
| | Mice | 2 | 2021 | 18261 | 0.030 |
Why?
| | Nitric Oxide Synthase Type I | 1 | 2013 | 30 | 0.030 |
Why?
| | Disulfides | 1 | 2013 | 94 | 0.020 |
Why?
| | Inhibitory Postsynaptic Potentials | 1 | 2013 | 47 | 0.020 |
Why?
| | Pyridazines | 1 | 2013 | 57 | 0.020 |
Why?
| | Regression Analysis | 1 | 2016 | 998 | 0.020 |
Why?
| | Health Status | 1 | 2018 | 834 | 0.020 |
Why?
| | Reaction Time | 1 | 2015 | 438 | 0.020 |
Why?
| | Protein Multimerization | 1 | 2013 | 207 | 0.020 |
Why?
| | Scalp | 1 | 2012 | 38 | 0.020 |
Why?
| | Crystallography, X-Ray | 1 | 2013 | 491 | 0.020 |
Why?
| | Cicatrix | 1 | 2012 | 69 | 0.020 |
Why?
| | Language | 1 | 2015 | 323 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2019 | 3414 | 0.020 |
Why?
| | Salmonella typhimurium | 1 | 2013 | 189 | 0.020 |
Why?
| | Antibodies, Neutralizing | 1 | 2013 | 341 | 0.020 |
Why?
| | Solubility | 1 | 2011 | 236 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2013 | 2019 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2018 | 5414 | 0.020 |
Why?
| | Models, Molecular | 1 | 2013 | 1610 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2015 | 3603 | 0.020 |
Why?
| | Sex Factors | 1 | 2012 | 2104 | 0.010 |
Why?
| | Quality of Life | 1 | 2018 | 3183 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2018 | 2950 | 0.010 |
Why?
| | Fibroblasts | 1 | 2011 | 1019 | 0.010 |
Why?
| | Cell Line | 1 | 2011 | 2821 | 0.010 |
Why?
| | DNA | 1 | 2011 | 1447 | 0.010 |
Why?
| | Celiac Disease | 1 | 2007 | 309 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2018 | 11735 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2011 | 2591 | 0.010 |
Why?
| | Aged | 1 | 2018 | 25955 | 0.010 |
Why?
| | Adolescent | 1 | 2015 | 22409 | 0.010 |
Why?
|
|
Welsh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|